HomeCXM • FRA
Chemed Corp
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 646.94M | 9.79% |
Operating expense | 121.66M | -3.78% |
Net income | 71.76M | 10.37% |
Net profit margin | 11.09 | 0.54% |
Earnings per share | 5.63 | 8.27% |
EBITDA | 110.78M | 18.50% |
Effective tax rate | 25.00% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 173.88M | -44.51% |
Total assets | 1.73B | -0.06% |
Total liabilities | 544.75M | 0.11% |
Total equity | 1.18B | — |
Shares outstanding | 14.57M | — |
Price to book | 6.17 | — |
Return on assets | 13.95% | — |
Return on capital | 18.32% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 71.76M | 10.37% |
Cash from operations | 32.74M | -61.27% |
Cash from investing | -13.67M | 29.46% |
Cash from financing | -23.54M | -49.24% |
Net change in cash | -4.47M | -109.05% |
Free cash flow | -34.57M | -162.43% |
Previous close
€500.00
Day range
€492.00 - €492.00
Year range
€476.00 - €575.00
Market cap
8.33B USD
Avg Volume
1.00
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
About
Founded
1970
Headquarters
Website
Employees
15,695